Samuel Grigg

12PUBLICATIONS
8CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 09, 2024
Relapse after glofitamab has a poor prognosis and rates of CD20 loss are high.

Samuel Grigg, Adrian Minson, Elizabeth Prins

|Nov 09, 2018
Helicobacter pylori and low-dose aspirin ulcer risk: A meta-analysis.

Gino L Sarri, Sam E Grigg, Neville D Yeomans

|Sep 28, 2018
Urine cultures at the onset of febrile neutropenia rarely impact antibiotic management in asymptomatic adult cancer patients.

Sam E Grigg, Patrick Date, Zoe Loh

Pageof 2